Translational research in kidney transplantation and the role of patient engagement
暂无分享,去创建一个
Meghan J. Elliott | S. Silver | Zsuzsanna Lichner | J. Farragher | M. Elliott | Zsuzsanna Lichner | Janine F. Farragher | Samuel A. Silver | Anne Tsampalieros | A. Tsampalieros
[1] L. Czer,et al. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ. , 1994, Transplantation.
[2] S. Greenstein,et al. Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. , 1998, Transplantation.
[3] J M Smith,et al. OPTN/SRTR 2012 Annual Data Report: Kidney , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] A. Bingaman,et al. Histocompatibility considerations for kidney paired donor exchange programs , 2012, Current opinion in organ transplantation.
[5] P. Stratta,et al. Quality of life in renal transplant patients over 60 years of age. , 2008, Transplantation proceedings.
[6] G. Forrest. Inpatient rehabilitation of patients requiring hemodialysis. , 2004, Archives of physical medicine and rehabilitation.
[7] D. Hathaway,et al. The first report from the patient outcomes registry for transplant effects on life (PORTEL): differences in side‐effects and quality of life by organ type, time since transplant and immunosuppressive regimens , 2003, Clinical transplantation.
[8] R. Colvin,et al. Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment , 2002, Current opinion in nephrology and hypertension.
[9] S. De Geest,et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens , 2006, Clinical transplantation.
[10] Alexander A Kon,et al. The Clinical and Translational Science Award (CTSA) Consortium and the Translational Research Model , 2008, The American journal of bioethics : AJOB.
[11] P. Reese,et al. Deceased-donor kidney perfusate and urine biomarkers for kidney allograft outcomes: a systematic review. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] M. Schnitzler,et al. Transplant Outcomes and Economic Costs Associated with Patient Noncompliance to Immunosuppression , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] D. Wishart,et al. Urinary Metabolomics for Noninvasive Detection of Borderline and Acute T Cell–Mediated Rejection in Children After Kidney Transplantation , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] D. Segev,et al. Kidney paired donation and optimizing the use of live donor organs. , 2005, JAMA.
[15] R. Montgomery,et al. Defining unacceptable HLA antigens. , 2008, Current opinion in organ transplantation.
[16] K. Tinckam. Histocompatibility methods. , 2009, Transplantation reviews.
[17] R. Kowalewski,et al. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study. , 2009, Transplantation proceedings.
[18] L. Kucirka,et al. Desensitization in HLA-incompatible kidney recipients and survival. , 2011, The New England journal of medicine.
[19] Susan Martin,et al. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. , 2008, Transplantation.
[20] S. Knechtle,et al. Urine proteomics in kidney transplantation. , 2014, Transplantation reviews.
[21] J. Westfall,et al. Practice-based research--"Blue Highways" on the NIH roadmap. , 2007, JAMA.
[22] D. Rubio,et al. Defining Translational Research: Implications for Training , 2010, Academic medicine : journal of the Association of American Medical Colleges.
[23] M. Fiatarone Singh,et al. Exercise Training in Patients Receiving Maintenance Hemodialysis: A Systematic Review of Clinical Trials , 2005, American Journal of Nephrology.
[24] S. Mulgaonkar,et al. Renal Transplantation in Patients With Pre‐Transplant Donor‐Specific Antibodies and Negative Flow Cytometry Crossmatches , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[25] A. Matas,et al. Graft and quality of life outcomes in older recipients of a kidney transplant. , 2003, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.
[26] R. Montgomery,et al. Transplanting the highly sensitized patient: trials and tribulations , 2013, Current opinion in nephrology and hypertension.
[27] J. Kanellis,et al. Understanding crossmatch testing in organ transplantation: A case‐based guide for the general nephrologist , 2011, Nephrology.
[28] R. Montgomery,et al. PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS , 2000, Transplantation.
[29] S. Reis,et al. Crossing the Research Valleys of Death: The University of Pittsburgh Approach , 2008, Clinical and Translational Science.
[30] M. Fernandez-Vina,et al. A HIGH PANEL-REACTIVE ANTIBODY RESCUE PROTOCOL FOR CROSS-MATCH-POSITIVE LIVE DONOR KIDNEY TRANSPLANTS1 , 2000, Transplantation.
[31] P. Terasaki,et al. Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[32] Michele Tarsilla. Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.
[33] P. Archdeacon,et al. Summary of FDA Antibody‐Mediated Rejection Workshop , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[34] Michael Hoerger,et al. Educating the Psychology Workforce in the Age of the Affordable Care Act: A Graduate Course Modeled after the Priorities of the Patient-Centered Outcomes Research Institute (PCORI). , 2015, Training and education in professional psychology.
[35] I. Doxiadis,et al. The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome. , 2004, Transplantation.
[36] Germaine Wong,et al. The perspectives of kidney transplant recipients on medicine taking: a systematic review of qualitative studies. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[37] P. Shekelle,et al. Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials , 2004, BMJ : British Medical Journal.
[38] A. Laupacis,et al. A study of the quality of life and cost-utility of renal transplantation. , 1996, Kidney international.
[39] R. Montgomery,et al. A GPS for finding the route to transplantation for the sensitized patient , 2012, Current opinion in organ transplantation.
[40] P. Glasziou,et al. Avoidable waste in the production and reporting of research evidence , 2009, The Lancet.
[41] S. Chadban,et al. Patients' priorities for health research: focus group study of patients with chronic kidney disease. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[42] S. Straus,et al. Learning in practice The case for knowledge translation : shortening the journey from evidence to effect , 2003 .
[43] A. Terzic,et al. Clinical and Translational Science: From Bench‐Bedside to Global Village , 2010, Clinical and translational science.
[44] Gerhard Opelz,et al. HLA matching and kidney transplantation: beyond graft survival. , 2013, Clinical transplants.
[45] E. Gordon,et al. Medication‐taking among adult renal transplant recipients: barriers and strategies , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[46] B. Hemmelgarn,et al. Research priority setting in kidney disease: a systematic review. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[47] J. Klein,et al. George Snell's first foray into the unexplored territory of the major histocompatibility complex. , 2001, Genetics.
[48] Iain Chalmers,et al. How to increase value and reduce waste when research priorities are set , 2014, The Lancet.
[49] R. Brook. Medical leadership in an increasingly complex world. , 2010, JAMA.
[50] J. Broerse,et al. Patient involvement in a scientific advisory process: setting the research agenda for medical products. , 2012, Health policy.
[51] H. Allore,et al. A program to prevent functional decline in physically frail, elderly persons who live at home. , 2002, The New England journal of medicine.
[52] F. Marincola. Translational Medicine: A two-way road , 2003, Journal of Translational Medicine.
[53] J. Cecka,et al. Current methodologies for detecting sensitization to HLA antigens , 2011, Current opinion in organ transplantation.
[54] K. Budde,et al. Identification and Therapeutic Management of Highly Sensitized Patients Undergoing Renal Transplantation , 2012, Drugs.
[55] J F Burdick,et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. , 1993, Kidney international.
[56] S. Staniszewska,et al. Mapping the impact of patient and public involvement on health and social care research: a systematic review , 2014, Health expectations : an international journal of public participation in health care and health policy.
[57] J. Haymann,et al. SUPPRESSION OF HLA‐SPECIFIC ALLOANTIBODIES BY HIGH‐DOSE INTRAVENOUS IMMUNOGLOBULINS (IVIg): A POTENTIAL TOOL FOR TRANSPLANTATION OF IMMUNIZED PATIENTS , 1993, Transplantation.
[58] R. Shapiro,et al. Antibody-Mediated Rejection in Kidney Transplantation: A Review , 2012, Journal of transplantation.
[59] J. Farragher,et al. A Cross-Sectional Study Examining the Functional Independence of Elderly Individuals With a Functioning Kidney Transplant , 2014, Transplantation.
[60] A. Halawa. The early diagnosis of acute renal graft dysfunction: a challenge we face. The role of novel biomarkers. , 2011, Annals of transplantation.
[61] A. Michael Borkon,et al. Successful renal transplantation despite low levels of donor‐specific HLA class I antibody without IVIg or plasmapheresis , 2006, Clinical transplantation.
[62] L. Lesko,et al. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. , 2001, Annual review of pharmacology and toxicology.
[63] P. Terasaki,et al. THE SIGNIFICANCE OF A POSITIVE FLOW CYTOMETRY CROSSHATCH TEST IN PRIMARY KIDNEY TRANSPLANTATION , 1993, Transplantation.
[64] P. Nickerson,et al. Detection of Subclinical Tubular Injury After Renal Transplantation: Comparison of Urine Protein Analysis With Allograft Histopathology , 2007, Transplantation.
[65] K. Wade,et al. Practice-Based Research , 2007, Social work in health care.
[66] G. Elwyn,et al. Identifying and prioritizing uncertainties: patient and clinician engagement in the identification of research questions. , 2010, Journal of evaluation in clinical practice.
[67] D. Butler. Translational research: Crossing the valley of death , 2008, Nature.
[68] Matthias Egger,et al. Inpatient rehabilitation specifically designed for geriatric patients: systematic review and meta-analysis of randomised controlled trials , 2010, BMJ : British Medical Journal.
[69] K. Tinckam,et al. Desensitization Outcomes: Quantifying and Questioning , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[70] P. Giannoudis,et al. Translational research: from benchside to bedside. , 2008, Injury.
[71] G. Guyatt,et al. The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature , 2008, Quality of Life Research.
[72] R. Marcus,et al. Antibody-mediated rejection following renal transplantation , 2007, Expert opinion on pharmacotherapy.
[73] S. Chadban,et al. The Treatment of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients—A Systematic Review , 2012, Transplantation.
[74] A Chkhotua,et al. Paired kidney donation: outcomes, limitations, and future perspectives. , 2012, Transplantation proceedings.
[75] S. Woolf. The meaning of translational research and why it matters. , 2008, JAMA.
[76] C. Haisch,et al. Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts , 2013, Transplantation.
[77] U. Heemann,et al. Quality of life in kidney recipients: comparison of tacrolimus and cyclosporine‐microemulsion , 2002, Clinical transplantation.
[78] P. Sinnott,et al. Pretransplant Donor-Specific Antibodies in Cytotoxic Negative Crossmatch Kidney Transplants: Are They Relevant? , 2008, Transplantation.
[79] H. Ishida,et al. Analysis of Predictive and Preventive Factors for De Novo DSA in Kidney Transplant Recipients , 2014, Transplantation.
[80] P. Nickerson,et al. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. , 2001, Journal of the American Society of Nephrology : JASN.
[81] R. Montgomery,et al. Renal Transplantation Across HLA and ABO Antibody Barriers: Integrating Paired Donation into Desensitization Protocols , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[82] A. Laupacis,et al. Setting research priorities for patients on or nearing dialysis. , 2014, Clinical journal of the American Society of Nephrology : CJASN.
[83] Mario Plebani,et al. What's next in translational medicine? , 2007, Clinical science.
[84] N. Heyne,et al. Urinary Neutrophil Gelatinase-Associated Lipocalin Accurately Detects Acute Allograft Rejection Among Other Causes of Acute Kidney Injury in Renal Allograft Recipients , 2012, Transplantation.
[85] Ethan M Balk,et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. , 2010, Kidney international.
[86] F. Dobbels,et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review , 2005, Transplant international : official journal of the European Society for Organ Transplantation.
[87] P. Tugwell,et al. Prevention and self-management interventions are top priorities for osteoarthritis systematic reviews. , 2013, Journal of clinical epidemiology.
[88] Stephen B. Johnson,et al. Central challenges facing the national clinical research enterprise. , 2003, JAMA.
[89] J. Platt,et al. A national conference to determine research priorities in pediatric solid organ transplantation , 2008, Pediatric transplantation.
[90] Cecka Jm. Current methodologies for detecting sensitization to HLA antigens. , 2011 .
[91] R. Colvin,et al. Banff 2011 Meeting Report: New Concepts in Antibody‐Mediated Rejection , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[92] M. Christiaans,et al. Clinical Relevance of Pretransplant Donor-Directed Antibodies Detected by Single Antigen Beads in Highly Sensitized Renal Transplant Patients , 2008, Transplantation.
[93] R. Walker,et al. Urinary tubular biomarkers as potential early predictors of renal allograft rejection , 2012, Nephrology.
[94] J. Dipiro,et al. Impact of clinical pharmacy services on renal transplant patients’ compliance with immunosuppressive medications , 2001, Clinical transplantation.
[95] P. Nickerson,et al. Evolution and Clinical Pathologic Correlations of De Novo Donor‐Specific HLA Antibody Post Kidney Transplant , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[96] M. Mitsnefes,et al. Kidney NGAL is a novel early marker of acute injury following transplantation , 2006, Pediatric Nephrology.
[97] B. Benacerraf. Significance and biological function of class II MHC molecules. Rous-Whipple Award lecture 1985. , 1985, The American journal of pathology.